Author/Authors :
Zhu، Jun نويسنده Department of Urology, Tianjin Medical University General Hospital, 154 Anshan Road, Heping District, Tianjin 300052, China. , , Yang، Changhai نويسنده Department of Urology, Tianjin Medical University General Hospital, 154 Anshan Road, Heping District, Tianjin 300052, China. , , Dong، Zhichun نويسنده Department of Urology, Tianjin Medical University General Hospital, 154 Anshan Road, Heping District, Tianjin 300052, China , , Li، Liming نويسنده Department of Urology, Tianjin Medical University General Hospital, 154 Anshan Road, Heping District, Tianjin 300052, China ,
Abstract :
Purpose: To explore the value and significance of neutrophil elastase (NE) in diagnosis of
type III prostatitis.
Materials and Methods: The prospective study recruited 123 patients diagnosed with type III
prostatitis (IIIA, 36 cases; IIIB, 87 cases) and 84 healthy controls, between April 2008 and July
2012. NE concentrations in expressed prostatic secretions (EPS), EPS routine examination,
bacterial culture and The National Institute of Health Chronic Prostatitis Symptom Index (NIHCPSI)
score were detected in all the subjects. Difference of NE, CPSI score, and withe blood
cell (WBC) count between 2 or more than 2 groups and relationships between NE concentrations
and WBC count were all analyzed.
Results: There was significant difference in levels of NE (P < .05) between IIIA and IIIB
groups, and obviously positive correlation between the level of NE and number of leukocyte
in type IIIA prostatitis group was observed (P < .05). The values of CPSI score between IIIA
and IIIB groups was statistically significant (P = .037). The levels of leukocyte mount, NE
and CPSI were statistically significant between IIIA and the control group (P < .05). NE concentration
and CPSI score were statistically significant between IIIB and control group (P <
.05), while the numbers of leukocyte was not statistically significant (P = .360).
Conclusion: The level of NE in EPS is a significant indicator in diagnosis of type IIIA and
IIIB prostatitis.